Cosfroviximab

• Target:

  Virus Protease

• Related Pathways:

  Microbiology/Virology

• Bioactivity:

  Cosfroviximab (c13C6-FR1) is a chimeric monoclonal antibody derived from mouse and human sources, designed to target the Ebola virus glycoprotein (EBOV-GP) [1].

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1792982-57-0